✦ LIBER ✦

Incidence, prescription patterns, and determinants of antipsychotic use in patients with Parkinson's disease

✍ Scribed by Meng-Ting Wang; Pei-Wen Lian; Chin-Bin Yeh; Che-Hung Yen; Kao-Hsing Ma; Agnes L.F. Chan

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 138 KB
Volume: 26
Category: Article
ISSN: 0885-3185
DOI: 10.1002/mds.23719

No coin nor oath required. For personal study only.

✦ Synopsis

Empirical data regarding the choice of antipsychotics for the management of psychosis in patients with Parkinson's disease are limited. This study aimed to evaluate the incidence and prescribing patterns of antipsychotics and to determine the predictors associated with the prescribing of typical antipsychotics in patients with Parkinson's disease. This was a retrospective cohort study analyzing data from the National Health Insurance Research Database in Taiwan between January 1, 2000, and December 31, 2006, in which patients with Parkinson's disease (ICD-9-CM codes 332) initially receiving any antiparkinsonian drug (n 5 2095) were followed up to evaluate the subsequent use of antipsychotics. Kaplan-Meier statistics and multiple logistic regression were employed to evaluate the cumulative probability of antipsychotic use and determinants of prescribing of typical antipsychotics, respectively. The cumulative probability of initiation of an antipsychotic within 6 years was found to be 51%, and the proportion of patients who began taking an atypical antipsychotic increased from 11.1% in 2001 to 36.1% in 2005. Physician specialty was found to be the most influential predictor of the prescribing of typical antipsychotics: physicians with an internal medicine specialty were 10.62 times more likely (95% confidence interval, 4.64-24.32) to prescribe typical antipsychotics than were neurologists. The use of antipsychotics in Parkinson's disease is common, and the use of typical antipsychotics dominates antipsychotic treatment. Particular attention needs to be paid to improving practice, including efforts that encourage primary care providers to have the appropriate choice of antipsychotics in patients with Parkinson's disease. V

📜 SIMILAR VOLUMES

Antipsychotic use in older adults with P

Antipsychotic use in older adults with Parkinson's disease

✍ Connie Marras; Alexander Kopp; Feng Qiu; Anthony E. Lang; Kathy Sykora; Kenneth 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 1 views

## Abstract The choice of agents to treat psychotic symptoms in Parkinson's disease is important given the potential for antipsychotics to worsen Parkinsonism. The purpose of this study was to estimate the incidence of psychotic symptoms requiring treatment in individuals with Parkinson's disease a

Incidence of Parkinson's disease among h

Incidence of Parkinson's disease among hospital patients with methamphetamine-use disorders

✍ Russell C. Callaghan; James K. Cunningham; Gautam Sajeev; Stephen J. Kish 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract Because methamphetamine exposure to experimental animals can damage brain dopamine neurones, we examined whether hospital patients diagnosed with methamphetamine‐related disorders might have greater risk of subsequent admission with a Parkinson's disease diagnosis. This was a population

Determinants of quality of life in Brazi

Determinants of quality of life in Brazilian patients with Parkinson's disease

✍ Francisco Javier Carod-Artal; Antonio Pedro Vargas; Pablo Martinez-Martin 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract Our objective was to identify determinants of health‐related quality of life (HRQoL) in a cohort of Brazilian patients with Parkinson's disease (PD). Patients were evaluated by means of the Hoehn and Yahr staging (H&Y), Unified Parkinson's Disease Rating Scale (UPDRS), Schwab and Englan

Use of complementary therapies in patien

Use of complementary therapies in patients with Parkinson's disease in Singapore

✍ Louis C.S. Tan; Puay-Ngoh Lau; Roland Dominic G. Jamora; Edwin S.Y. Chan 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 1 views

## Abstract To determine the frequency and spectrum of complementary therapy (CT) use and its association with sociodemographic or disease‐specific characteristics among Asian patients with Parkinson's disease (PD) in Singapore, we interviewed 159 patients using a structured questionnaire. Sixty‐on

Depressive symptom patterns in patients

Depressive symptom patterns in patients with Parkinson's disease and other older adults

✍ Kristi J. Erdal 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 153 KB 👁 1 views

## Abstract Research on depression in Parkinson's disease (PD) has suggested that PD patients experience a qualitatively different depression from that of other older adults, endorsing fewer cognitive symptoms of depression (e.g., guilt, failure) and greater somatic (e.g., poor sleep) and mood symp

Akathisia as a side effect of antipsycho

Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease

✍ Christian Prueter; Benedikt Habermeyer; Christine Norra; Christoph M. Kosinski 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 1 views

## Abstract Due to its low profile for extrapyramidal side‐effects, quetiapine has become an alternative to clozapine in the treatment of dopamimetic psychosis in patients with Parkinson's disease (PD). We describe the case of a patient with PD who developed severe akathisia, a common complication